References
- Estcourt L, Stanworth S, Doree C, et al. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev. 2012;5:CD004269.
- Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med. 2010;362(7):600–613. doi: https://doi.org/10.1056/NEJMoa0904084
- Stanworth SJ, Estcourt LJ, Powter G, et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med. 2013;368(19):1771–1780. doi: https://doi.org/10.1056/NEJMoa1212772
- Andreu G, Vasse J, Sandid I, et al. Use of random versus apheresis platelet concentrates. Transfus Clin Biol. 2007;14(6):514–521. doi: https://doi.org/10.1016/j.tracli.2008.01.004
- Thiele T, Alt-Mayer T, Greinacher A, et al. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis. Vox Sang. 2016;111(4):350–356. doi: https://doi.org/10.1111/vox.12433
- Rivera J, Lozano ML, Vicente V. In vitro changes of platelet parameters: lessons from blood banking. Methods Mol Biol. 2004;273:57–72.
- Cardigan R, Turner C, Harrison P. Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sang. 2005;88(3):153–163. doi: https://doi.org/10.1111/j.1423-0410.2005.00618.x
- Slichter SJ, Davis K, Enright H, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood. 2005;105(10):4106–4114. doi: https://doi.org/10.1182/blood-2003-08-2724
- Triulzi DJ, Assmann SF, Strauss RG, et al. The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia. Blood. 2012;119(23):5553–5562. doi: https://doi.org/10.1182/blood-2011-11-393165
- Van der Planken MG, Vertessen F, Mortelmans E, et al. The evolution of platelet procoagulant activity of remnant platelets in stored platelet concentrates prepared by the platelet-rich plasma method and the buffy coat method. Ann Hematol. 1999;78(1):1–7. doi: https://doi.org/10.1007/s002770050463
- Metcalfe P, Williamson LM, Reutelingsperger CP, et al. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Br J Haematol. 1997;98(1):86–95. doi: https://doi.org/10.1046/j.1365-2141.1997.1572983.x
- Semple E, Bowes-Schmidt A, Yi Q-L, et al. Transfusion reactions: a comparative observational study of blood components produced before and after implementation of semiautomated production from whole blood. Transfusion. 2012;52(12):2683–2691. doi: https://doi.org/10.1111/j.1537-2995.2012.03752.x
- Heddle NM, Arnold DM, Boye D, et al. Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review. Transfusion. 2008;48(7):1447–1458. doi: https://doi.org/10.1111/j.1537-2995.2008.01731.x
- Singh RP, Marwaha N, Malhotra P, et al. Therapeutic efficacy of different types of platelet concentrates in thrombocytopenic patients. Indian J Hematol Blood Transfus. 2008;24(1):16–22. doi: https://doi.org/10.1007/s12288-008-0024-9
- Van der Meer PF. Platelet concentrates, from whole blood or collected by apheresis? Transfus Apher Sci. 2013;48(2):129–131. doi: https://doi.org/10.1016/j.transci.2013.02.004
- Rivera J, Sánchez-Roig MJ, Rosillo MC, et al. Stability of glycoproteins Ib/IX and IIb/IIIa during preparation and storage of platelet concentrates: detection by binding assays with epitope-defined monoclonal antibodies and physiological ligands. Vox Sang. 1994;67(2):166–171.
- Plaza EM, Céspedes P, Fernández H, et al. Quality assessment of buffy-coat-derived leucodepleted platelet concentrates in PAS-plasma, prepared by the OrbiSac or TACSI automated system. Vox Sang. 2014;106(1):38–44. doi: https://doi.org/10.1111/vox.12072
- Bishop JF, Matthews JP, Yuen K, et al. The definition of refractoriness to platelet transfusions. Transfus Med. 1992;2(1):35–41. doi: https://doi.org/10.1111/j.1365-3148.1992.tb00132.x
- Anderson NA, Gray S, Copplestone JA, et al. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions. Transfus Med. 1997;7(1):33–39. doi: https://doi.org/10.1046/j.1365-3148.1997.d01-73.x
- Bishop JF, McGrath K, Wolf MM, et al. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood. 1988;71(2):383–387.
- Bensinger W, Petersen FB, Banaji M, et al. Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission. Bone Marrow Transplant. 1989;4(4):409–414.
- Ishida A, Handa M, Wakui M, et al. Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation – a prospective analysis. Transfusion. 1998;38(9):839–847. doi: https://doi.org/10.1046/j.1537-2995.1998.38998409004.x
- Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto. N Engl J Med. 1997;337(26):1870–1875. doi: https://doi.org/10.1056/NEJM199712253372602
- Estcourt LJ, Heddle N, Kaufman R, et al. The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions. Transfusion. 2013;53(7):1531–1543. doi: https://doi.org/10.1111/trf.12058
- Stanworth SJ, Estcourt LJ, Llewelyn CA, et al. Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial (CME). Transfusion. 2014;54(10):2385–2393. doi: https://doi.org/10.1111/trf.12646
- Liesveld J, Pawlowski J, Chen R, et al. Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis. Bone Marrow Transplant. 2013;48(5):691–697. doi: https://doi.org/10.1038/bmt.2012.194
- Böck M, Muggenthaler KH, Schmidt U, et al. Influence of antibiotics on posttransfusion platelet increment. Transfusion. 1996;36(11–12):952–954. doi: https://doi.org/10.1046/j.1537-2995.1996.36111297091736.x